There have been 4 patients in our series whose deaths were unexplained at necropsy and who displayed many of these features before death. It seems likely that these deaths can be attributed directly to sympathetic overactivity which may also have been a contributory factor in other fatalities since it has been stressed that prolonged sympathetic stimulation has a wide range of deleterious effects, particularly cardiac and vascular ones (Raab 1966 Patients with severe tetanus are routinely treated by a regime of tracheostomy, curarization, adequate sedation and intermittent positive pressure ventilation (IPPV). Anticoagulant therapy is also used prophylactically to prevent peripheral deep venous thrombosis and pulmonary embolism (Kerr et al. 1968 ). This paper describes the results of supplementary therapy to control severe cardiovascular disturbances in 4 patients with severe tetanus, all of whom recovered. It should be stressed that these cardiovascular disturbances in tetanus can carry a high mortality.
The form of therapy used derives from the suggestion that the clinical and physiological syndrome already described may be due to sympathetic overactivity. The aim has been to suppress such overactivity, where it exists, by three pharmacological methods: (1) The use of drugs having nonspecific anti-adrenergic activity: phenothiazine derivatives. (2) Nonspecific suppression of neuronal activity using general antsthetic agents. (3) Specific suppression of adrenergic transmission at nerve-endings and receptors (Prys-Roberts et al. 1969) .
Phenothiazines: Chlorpromazine, promazine and promethazine are widely used as general sedatives and tranquillizers in the management of tetanus. The severe disturbances already described occurred despite the use of large doses of chlorpromazine (up to 1,200 mg/48 hours), and intravenous administration of chlorpromazine (I -6 mg/kg in patients S M and P S) produced only a transient reduction of arterial pressure and had little or no effect on the labile tachycardia. It has been our general impression that chlorpromazine, although a useful general sedative in mild or moderate tetanus, does not provide satisfactory control of the cardiovascular disturbances arising in severe tetanus.
General ancesthetic agents: Nitrous oxide has been shown to suppress the circulatory disturbances in tetanus (Prys-Roberts et al. 1967) but long-term use of this agent is precluded by the dangers of bone marrow depression (Lassen et al. 1956 ). Nitrous oxide (60%) was used successfully as a temporary measure in patients S M and P S for periods of twelve hours only. Anesthesia with 0-3-1 % halothane vaporized in air was subsequently used in patient S M for a period of four days, and this controlled the cardiovascular disturbances during this time. There was mild circulatory instability following withdrawal of halothane, but this regressed spontaneously. Anasthesia with trichloroethylene (0 3-0 5 %) vaporized in air, was used in patient P S. Initially this suppressed both the marked hypertension and tachycardia, the values falling to 120/80 mmHg and 100 per minute respectively (compare with maximum values in Table 1 ). Over a period of thirty-six hours, however, there was a progressive increase in heart rate even though arterial and central venous pressures remained normal. Ten hours after withdrawal of trichloroethylene, heart rate increased to 180-200 associated with multifocal ventricular extrasystoles interspersed with a supraventricular tachycardia.
Although general anaesthesia appears satisfactorily to suppress the cardiovascular disturbances in tetanus, prolonged use of any agent has its dangers, and the lack of communication with the anxesthetized patient is regarded as a major disadvantage.
Specific blockade of adrenergic transmission: By analogy with the neuromuscular blockade used to suppress the somatic manifestation of tetanus, it seemed logical to control the cardiovascular disturbances by blocking adrenergic effector mechanisms. Blockade of ,-adrenergic receptors (Ahlquist 1948) was used in patients P S and W B, both of whom showed labile tachycardia with arrhythmicity of both atrial and ventricular origin. In P S, propranolol (3 mg) was administered intravenously over a period of fifteen minutes using 0-2 mg increments, and reduced the heart rate from 180 to 120 per minute (Fig l) . Subsequent intragastric administration of propranolol (10 mg 8-hourly) further reduced heart rate to between 95 and 100 per minute. A similar effect was achieved in W B, propranolol being given initially by the intravenous route in small incremental doses, and subsequently by intragastric administration of 10 mg 6-hourly. In both patients, the heart rate was maintained at a stable and normal level until their tetanus had subsided.
Subsequent labile hypertension without changes in heart rate was interpreted as evidence of excessive activity at a-adrenergic receptors. It was felt that the combination of relatively long-acting a and P blockade would leave the cardiovascular system effectively denervated and refractory to stimulation. It was therefore decided that it would be preferable to use drugs which block noradrenaline activity in postganglionic nerves, thus leaving the a receptors intact. Bethanidine was administered in 3 patients by the intragastric route 10 mg 8-hourly (P S) or 5 mg 2-hourly (W B, D W) and maintained a stable, normal arterial pressure for the duration of IPPV. The combination of propranolol and bethanidine by intragastric tube was found to be a satisfactory method of controlling severe cardiovascular disturbances in patients with severe tetanus. No other modification of the standard regime was required.
Dr H R Dingle (Cardiff)described 10 patients with polyneuritis requiring IPPR of whom 8 had developed hypertension (usually fluctuating), all had tachycardia, 3 had raised urinary VMA levels and 6 a diabetic glucose tolerance response (4 returning to normal before discharge). Sympathetic hyperactivity was thus a feature of polyneuritis as well as tetanus. Additional findings in polyneuritis were increased urinary 17-hydroxycorticoids in 3 patients, the demonstration of the syndrome of inappropriate secretion of ADH in one patient with strong evidence of the syndrome in another 4, and a raised protein-bound iodine level in 2 patients. He asked if there was any evidence of similar widespread hypothalamohypophyseal derangement in tetanus.
Dr Spalding replied that Dr Dingle's observations showed that there was need for further detailed observation of patients with acute polyneuritis.
Professor John W Dundee (Queen's University, Belfast) said that blood pressure fluctuations were unpredictable in tetanus and would be very severe in some patients, while absent in others who had a wound of similar severity and a comparable incubation time. Unfortunately, estimation of blood catecholamines by the tri-hydroxyindole method was very time-consuming and results were not available for about forty-eight hours, so specific treatment must be carried out on the assumption that such a rise had occurred. A significant increase in blood catecholamines had been found only early in the course of the disease. Later fluctuations of blood pressure had not been accompanied by demonstrable rises. It was at this period that severe, and often fatal, hypotension would suddenly occur. An interesting, but as yet unexplored, line of treatment would be the routine use of a drug which would interfere with catecholamine production.
Dr H R Youngman (Addenbrooke's Hospital, Cambridge) said that the sympathetic overactivity syndrome lhad not been encountered in a series of 59 cases of tetanus at Cambridge since 1954. The only significant difference between their management of severe cases and that in most other centres was in the sedative used: nearly all the patients had received large doses of paraldehyde throughout the disease by nasogastric tube or by injection, and all other sedative tranquillizing and anticonvulsive drugs had been avoided. Dr Youngman thought paraldehyde had the same central antisympathetic effect as the halothane used in 2 cases by Dr Prys-Roberts, but without the dangers he mentioned. As it also provided very helpful sedation without side-effects, Dr Youngman felt it was preferable to the combination of a-and P-adrenergic blockers.
Dr Leslie Cole (Addeuibrooke's Hospital, Cambridge) wished to confirm the value of paraldehyde which he had used as a sedative in tetanus for over twenty years. This had proved particularly useful and free from side-effects in their series, especially in severe cases treated with curare and artificial ventilation but without other adjuvants.
